50.50EUR+8.02%Mkt Cap: 2.79B EURP/E: 24.09Last update: 2026-05-14
Dermapharm Holding SE, together with its subsidiaries, manufactures and sells off-patent branded pharmaceutical products in Germany, Italy, France, Austria, Switzerland, Spain, Portugal, the Netherlands, Croatia, Poland,…
Industry Peers
Drug Manufacturers - Specialty & Genericloading…
Indicators:|
Key Statistics
Valuation
P/E (Trailing)24.09
P/E (Forward)17.71
PEG—
P/B3.77
P/S2.35
EV/EBITDA13.04
EV/Revenue3.03
EPS (TTM)2.15
EPS (Forward)2.92
Cash Flow & Leverage
FCF Yield5.85%
FCF Margin13.75%
Operating CF201.38M EUR
CapEx (TTM)38.24M EUR
Net Debt/EBITDA2.95
Net Debt813.54M EUR
Technical
SMA 5044.28 (+14.0%)
SMA 20037.53 (+34.6%)
Beta—
S&P 52W Chg24.23%
Avg Vol (30d)23.16K
Avg Vol (10d)18.64K
Technical Indicators
RSI (14)74.1
MACD1.1091
MACD Signal0.9947
MACD Hist.+0.1144
BB Upper48.48 EUR
BB Middle46.34 EUR
BB Lower44.21 EUR
BB Width9.21%
ATR (14)1.472 EUR
Vol Ratio (20d)1.80x
52W Range
31.7094% of range51.80
52W High51.80 EUR
52W Low31.70 EUR
Profitability
Gross Margin64.96%
EBITDA Margin23.25%
Profit Margin9.64%
Oper. Margin22.16%
ROE18.83%
ROA5.47%
Revenue Growth4.50%
Earnings Growth35.50%
Balance Sheet
Debt/Equity1.62
Current Ratio2.00
Quick Ratio0.93
Book Value/Sh13.73 EUR
Cash/Share4.199 EUR
Dividends
Fwd Div Rate0.8800 EUR
Trail. Div Rate0.8800 EUR
Div. Yield1.70%
5Y Avg Yield2.79%
Payout Ratio41.86%
Ex-Div DateJun 29, 2026
Pay Date—
Ownership
Shares Out.53.84M
Float3.76M
Insiders83.77%
Institutions11.39%
Analyst Consensus
Rating2.2 (Buy)
Target (Mean)47.88 EUR
Target Range34.00 EUR – 60.00 EUR
# Analysts4
Company
Market Cap2.79B EUR
Enterprise Value3.60B EUR
Revenue (TTM)1.19B EUR
Gross Profit767.07M EUR
Net Income (TTM)113.79M EUR
Revenue/Share22.05 EUR
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees3.5K
Last Price50.50 EUR
CountryDE
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
ISINDE000A2GS5D8